Loading...

Bonesupport Holding AB (publ)

0RQO.LLSE
Healthcare
Medical - Pharmaceuticals
£315.89
£-9.69(-2.98%)

Bonesupport Holding AB (publ) (0RQO.L) Financial Performance & Statements

Review Bonesupport Holding AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
52.05%
52.05%
Operating Income Growth
1092.73%
1092.73%
Net Income Growth
-45.41%
45.41%
Operating Cash Flow Growth
460.19%
460.19%
Operating Margin
16.49%
16.49%
Gross Margin
92.60%
92.60%
Net Profit Margin
12.26%
12.26%
ROE
17.73%
17.73%
ROIC
22.02%
22.02%

Bonesupport Holding AB (publ) (0RQO.L) Financial Statements

Explore quarterly and annual reports for Bonesupport Holding AB (publ) stock.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$283.54M$257.01M$237.50M$219.79M
Cost of Revenue$21.007M$18.98M$16.87M$17.00M
Gross Profit$262.54M$238.03M$220.63M$202.79M
Gross Profit Ratio$0.93$0.93$0.93$0.92
R&D Expenses$23.81M$21.84M$19.68M$20.32M
SG&A Expenses$129.45M$131.44M$153.74M$152.76M
Operating Expenses$232.89M$173.81M$179.67M$173.08M
Total Costs & Expenses$253.90M$192.79M$196.54M$190.08M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$349000.00$209000.00
Depreciation & Amortization$1.84M$1.27M$1.88M$1.90M
EBITDA$31.47M$65.48M$42.84M$31.62M
EBITDA Ratio$0.11$0.25$0.18$0.14
Operating Income$29.65M$64.22M$40.96M$29.71M
Operating Income Ratio$0.10$0.25$0.17$0.14
Other Income/Expenses (Net)-$16.56M$7.85M-$349000.00-$1.25M
Income Before Tax$13.09M$72.07M$40.61M$28.47M
Income Before Tax Ratio$0.05$0.28$0.17$0.13
Income Tax Expense$2.66M$18.16M$10.04M$1.04M
Net Income$10.43M$53.91M$30.57M$27.43M
Net Income Ratio$0.04$0.21$0.13$0.12
EPS$0.16$0.82$0.46$0.42
Diluted EPS$0.16$0.81$0.46$0.41
Weighted Avg Shares Outstanding$65.86M$65.83M$65.76M$65.72M
Weighted Avg Shares Outstanding (Diluted)$66.82M$66.82M$66.74M$66.69M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;